{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:55:10Z","timestamp":1740135310435,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Aplastic anemia (AA) is a rare but fatal disorder characterized by pancytopenia due to bone marrow hypoplasia. Anti-glomerular basement membrane disease (anti-GBM disease) is an immune complex small-vessel vasculitis that presents as rapidly progressive glomerulonephritis and\/or pulmonary hemorrhage. Although both involve autoreactive T cells that are partially triggered by human leukocyte antigen (HLA)-DR15, there have been no reports of their co-existence and the treatment strategy is not well understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 67-year-old woman presented with fever, malaise, and acute kidney injury with proteinuria and hematuria requiring hemodialysis. She was diagnosed with anti-GBM antibody disease based on high serum anti-GBM antibody titer and crescentic glomerulonephritis on a renal biopsy. Pulse administration of methylprednisolone (MP), oral prednisolone (PSL), and plasmapheresis were performed. Only 2\u2009weeks after the diagnosis of anti-GBM disease, the patient developed pancytopenia requiring frequent blood transfusions. The blood cell count did not recover even 1\u2009month after discontinuing the drugs that could cause pancytopenia. Bone marrow examination showed hypocellularity without abnormal infiltrates or fibrosis, which led to the diagnosis of severe acquired AA. Further HLA phenotyping revealed that she had HLA-DR15. Increased dose of PSL with the secondary MP pulse and the addition of cyclosporine improved pancytopenia. Although she remained dialysis-dependent, anti-GBM disease and pancytopenia did not recur for more than 2\u2009years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We report the first case of acquired AA complicated with anti-GBM disease in an elderly woman with HLA-DR15, which was successfully treated with immunosuppressive therapy (IST). This report is valuable not only because it shows they may co-occur, but also because it provides a therapeutic option for this complex condition. It was also suggested that pancytopenia in patients with anti-GBM disease recalls serious hematologic diseases including AA that require immediate treatment based on bone marrow examination.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-022-02772-0","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T13:03:42Z","timestamp":1649336622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acquired aplastic anemia complicated with anti-glomerular basement membrane disease successfully treated with immunosuppressive therapy: a case report"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2897-2285","authenticated-orcid":false,"given":"Kenji","family":"Matsui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Mochida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Ishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumi","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayasu","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yotaro","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"issue":"10","key":"2772_CR1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3324\/haematol.2017.169862","volume":"102","author":"K Vaht","year":"2017","unstructured":"Vaht K, G\u00f6ransson M, Carlson K, et al. Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000\u20132011. Haematologica. 2017;102(10):1683\u201390.","journal-title":"Haematologica"},{"issue":"1","key":"2772_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1\u201311.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2772_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12185-015-1787-z","volume":"101","author":"M Miano","year":"2015","unstructured":"Miano M, Dufour C. The diagnosis and treatment of aplastic anemia: a review. Int J Hematol. 2015;101(6):527\u201335.","journal-title":"Int J Hematol"},{"issue":"7","key":"2772_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00277-008-0671-9","volume":"88","author":"MP Stalder","year":"2009","unstructured":"Stalder MP, Rovo A, Halter J, et al. Aplastic anemia and concomitant autoimmune diseases. Ann Hematol. 2009;88(7):659\u201365.","journal-title":"Ann Hematol"},{"issue":"1","key":"2772_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00296-003-0318-z","volume":"24","author":"NP Singh","year":"2004","unstructured":"Singh NP, Prakash A, Garg D, et al. Aplastic anemia complicating systemic lupus erythematosus: successful management with cyclosporine. Rheumatol Int. 2004;24(1):40\u20132.","journal-title":"Rheumatol Int"},{"issue":"5","key":"2772_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2169\/internalmedicine.36.371","volume":"36","author":"N Matsumoto","year":"1997","unstructured":"Matsumoto N, Kagawa H, Ichiyoshi H, et al. Aplastic anemia complicating Sjogren's syndrome. Intern Med. 1997;36(5):371\u20134.","journal-title":"Intern Med"},{"issue":"8","key":"2772_CR7","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1016\/j.leukres.2009.01.015","volume":"33","author":"GE Pamuk","year":"2009","unstructured":"Pamuk GE, Pamuk ON, Umit EG, Puyan FO, Ozturk E, Demir M. Antineutrophil cytoplasmic antibody associated vasculitis in one patient with severe aplastic anemia: description of the first case. Leuk Res. 2009;33(8):e95\u20137.","journal-title":"Leuk Res"},{"issue":"7","key":"2772_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2215\/CJN.01380217","volume":"12","author":"SP McAdoo","year":"2017","unstructured":"McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12(7):1162\u201372.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"31","key":"2772_CR9","doi-asserted-by":"publisher","first-page":"e16649","DOI":"10.1097\/MD.0000000000016649","volume":"98","author":"M Zhang","year":"2019","unstructured":"Zhang M, Guan N, Zhu P, et al. Recurrent anti-GBM disease with T-cell large granular lymphocytic leukemia: a case report. Medicine. 2019;98(31):e16649.","journal-title":"Medicine"},{"issue":"6","key":"2772_CR10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1053\/j.ajkd.2018.01.029","volume":"71","author":"Q-H Gu","year":"2018","unstructured":"Gu Q-H, Jia X-Y, Hu S-Y, et al. The clinical and immunologic features of patients with combined anti-GBM disease and castleman disease. Am J Kidney Dis. 2018;71(6):904\u20138.","journal-title":"Am J Kidney Dis"},{"key":"2772_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.12659\/AJCR.891067","volume":"15","author":"A Basnet","year":"2014","unstructured":"Basnet A, Cholankeril MR. Hemophagocytic lymphohistiocytosis in a patient with Goodpasture's syndrome: a rare clinical association. Am J Case Rep. 2014;15:431\u20136.","journal-title":"Am J Case Rep"},{"issue":"5","key":"2772_CR12","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","volume":"183","author":"J Wang","year":"2020","unstructured":"Wang J, Jelcic I, M\u00fchlenbruch L, et al. HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis. Cell. 2020;183(5):1264\u20131281.e20.","journal-title":"Cell"},{"issue":"1","key":"2772_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exphem.2006.09.002","volume":"35","author":"C Sugimori","year":"2007","unstructured":"Sugimori C, Yamazaki H, Feng X, et al. Roles of DRB1\u22171501 and DRB1\u22171502 in the pathogenesis of aplastic anemia. Exp Hematol. 2007;35(1):13\u201320.","journal-title":"Exp Hematol"},{"issue":"10","key":"2772_CR14","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1093\/ndt\/gfn179","volume":"23","author":"W Kitagawa","year":"2008","unstructured":"Kitagawa W, Imai H, Komatsuda A, et al. The HLA-DRB1*1501 allele is prevalent among Japanese patients with anti-glomerular basement membrane antibody-mediated disease. Nephrol Dial Transplant. 2008;23(10):3126\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2772_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"DC Cattran","year":"2012","unstructured":"Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza FC, Mezzano SA, et al. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl. 2012;2(2):139\u2013274.","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"2772_CR16","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3324\/haematol.2012.066217","volume":"98","author":"Y Seiki","year":"2013","unstructured":"Seiki Y, Sasaki Y, Hosokawa K, et al. Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure. Haematologica. 2013;98(6):901\u20137.","journal-title":"Haematologica"},{"issue":"6","key":"2772_CR17","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1182\/blood.V96.6.2049","volume":"96","author":"S Kojima","year":"2000","unstructured":"Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 2000;96(6):2049\u201354.","journal-title":"Blood"},{"issue":"5","key":"2772_CR18","first-page":"249","volume":"9","author":"H Dunckley","year":"1991","unstructured":"Dunckley H, Chapman JR, Burke J, et al. HLA-DR and -DQ genotyping in anti-GBM disease. Dis Markers. 1991;9(5):249\u201356.","journal-title":"Dis Markers"},{"issue":"2","key":"2772_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/ki.1993.245","volume":"44","author":"B Huey","year":"1993","unstructured":"Huey B, McCormick K, Capper J, et al. Associations of HLA-DR and HLA-DQ types with anti-GBM nephritis by sequence-specific oligonucleotide probe hybridization. Kidney Int. 1993;44(2):307\u201312.","journal-title":"Kidney Int"},{"issue":"1","key":"2772_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ki.1997.27","volume":"51","author":"M Fisher","year":"1997","unstructured":"Fisher M, Pusey CD, Vaughan RW, Rees AJ. Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. Kidney Int. 1997;51(1):222\u20139.","journal-title":"Kidney Int"},{"issue":"2","key":"2772_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/BF02907803","volume":"3","author":"SI Kapusttn","year":"1997","unstructured":"Kapusttn SI, Popova TI, Lyschov AA, Togo AV, Abdulkadyrov KM, Blinov MN. HLA-DR2 frequency increase in severe aplastic anemia patients is mainly attributed to the prevalence of DR15 subtype. Pathol Oncol Res. 1997;3(2):106\u20138.","journal-title":"Pathol Oncol Res"},{"issue":"5","key":"2772_CR22","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood.V100.5.1570.h81702001570_1570_1574","volume":"100","author":"Y Saunthararajah","year":"2002","unstructured":"Saunthararajah Y, Nakamura R, Nam J-M, et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood. 2002;100(5):1570\u20134.","journal-title":"Blood"},{"issue":"6","key":"2772_CR23","first-page":"5501","volume":"11","author":"SAA Qahtani","year":"2018","unstructured":"Qahtani SAA. Drug-induced megaloblastic, aplastic, and hemolytic anemias: current concepts of pathophysiology and treatment. Int J Clin Exp Med. 2018;11(6):5501\u201312.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2772_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s40800-018-0093-0","volume":"5","author":"Z Yu","year":"2018","unstructured":"Yu Z, Hu J, Hu Y. Neutropenia and thrombocytopenia induced by proton pump inhibitors: a case report. Drug Saf Case Rep. 2018;5(1):28.","journal-title":"Drug Saf Case Rep"},{"issue":"8","key":"2772_CR25","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","volume":"108","author":"NS Young","year":"2006","unstructured":"Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8):2509\u201319.","journal-title":"Blood"},{"key":"2772_CR26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0609.1996.tb01641.x","volume":"60","author":"DW Kaufman","year":"1996","unstructured":"Kaufman DW, Kelly JP, Jurgelon JM, et al. Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl. 1996;60:23\u201330.","journal-title":"Eur J Haematol Suppl"},{"issue":"2","key":"2772_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"SB Killick","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172(2):187\u2013207.","journal-title":"Br J Haematol"},{"issue":"5","key":"2772_CR28","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood.V86.5.2055a.bloodjournal8652055a","volume":"86","author":"O Ilhan","year":"1995","unstructured":"Ilhan O, Beksac M, Koc H, et al. HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapy. Blood. 1995;86(5):2055.","journal-title":"Blood"},{"issue":"4","key":"2772_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/030006059702500409","volume":"25","author":"Y Morishita","year":"1997","unstructured":"Morishita Y, Matsukawa Y, Kura Y, et al. Antithymocyte globulin for a patient with systemic lupus erythematosus complicated by severe pancytopenia. J Int Med Res. 1997;25(4):219\u201323.","journal-title":"J Int Med Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02772-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02772-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02772-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T19:27:52Z","timestamp":1700422072000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02772-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2772"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02772-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}